SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-20-000035
Filing Date
2020-08-11
Accepted
2020-08-11 06:45:47
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axon-20200630.htm   iXBRL 10-Q 1435202
2 EX-31.1 a063020exhibit311.htm EX-31.1 12577
3 EX-31.2 a063020exhibit312.htm EX-31.2 12717
4 EX-32.1 a063020exhibit321.htm EX-32.1 7519
5 EX-32.2 a063020exhibit322.htm EX-32.2 7517
11 axon-20200630_g1.jpg GRAPHIC 191630
  Complete submission text file 0001636050-20-000035.txt   5124306

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20200630.xsd EX-101.SCH 33071
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20200630_cal.xml EX-101.CAL 53518
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20200630_def.xml EX-101.DEF 167034
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20200630_lab.xml EX-101.LAB 413206
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20200630_pre.xml EX-101.PRE 271087
12 EXTRACTED XBRL INSTANCE DOCUMENT axon-20200630_htm.xml XML 429168
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 201091017
SIC: 2834 Pharmaceutical Preparations